Adolescent Fibromyalgia Study

Completed · Phase 4 · Has a placebo group

Conditions studied: Fibromyalgia

In brief

This study will compare pregabalin with placebo over a 15 week period in adolescents with fibromyalgia aged 12-17 years to evaluate the safety and efficacy of pregabalin.

Key facts

Study ID
NCT01020474
Run by
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
People needed
107
Starts
2010-05-01
Expected to finish
2014-12-01
Last updated by the study team
2021-01-28

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.